Ana samun karuwar samari da suka kamu da tabar wiwi. Akwai bukatar girma don magance wannan jarabar yadda ya kamata, in ji masana. A halin yanzu babu wani magani da FDA ta amince da shi don magani. Akwai gwaji tare da magani. A cikin wani ɗan ƙaramin binciken da aka buga a Nature Medicine, kwayar gwaji ta nuna alƙawarin magance matsalar amfani da tabar wiwi.
An gano magungunan (AEF-0117) don rage fa'idodin cannabis da ake tsammani har zuwa kashi 38 a cikin makafi biyu, bazuwar, sarrafawa na Phase 2a wanda masu binciken Jami'ar Columbia suka jagoranta. Meg Haney, shugaban marubucin binciken kuma darektan dakin binciken cannabis a Jami'ar Columbia, ya kira sakamakon gwajin yana da kwarin gwiwa.
An kiyasta cewa kimanin kashi 30 cikin dari na masu amfani suna fama da jaraba. Kimanin Amurkawa miliyan 14 ke nan, a cewar rahoton Abuse Abuse and Mental Health Service Administration rahoton.
Magani ga jaraba
da magani an yi nazari a cikin manya maza da mata 29 da aka gano da rashin amfani. Sun sha kusan gram 3 na marijuana a rana, kwana shida a mako. Hanyoyin maganin da aka yi nazari sun kasance ƙananan kashi na 0,06 milligrams (MG) da kuma mafi girma na 1 milligram.
Mahalarta sun fara gwajin ta hanyar fara ba su ko dai magani ko placebo na kwanaki biyar. Sun sha maganin a karfe 9.00 na safe kowace rana kuma suna shan taba mai karfin tabar wiwi bayan sa'o'i 3,5. Daga nan an bincika su daga shan taba sigari na mintuna 20 zuwa sa'o'i 2 bayan shan taba.
Ƙananan kashi ya rage tasirin tabar wiwi da kashi 19, yayin da mafi girman kashi ya rage shi da kashi 38. Mafi girman kashi ne kawai ya iya rage adadin cannabis da mahalarta suka ƙare amfani da su daga baya a rana. Babu wani tasiri mai mahimmanci kuma miyagun ƙwayoyi bai haifar da alamun janyewa ba.
Haney: "Abubuwan da aka samu na karamin binciken yana buƙatar tabbatar da su a cikin manyan binciken da ke ci gaba. Kimanin marasa lafiya 300 a duk faɗin ƙasar suna shiga cikin gwajin lokaci na 2b. Ana sa ran samun sakamako a farkon shekara mai zuwa.
Mai aiki a cikin kwakwalwa
Maganin, wanda kamfanin fasahar kere-kere na Faransa Aelis FarmaCannabis ya kirkira, ya sha bamban da yadda yake kai wa kwakwalwa hari ta wata hanya. THC, fili na psychoactive, yana ɗaure ga mai karɓa a cikin kwakwalwa da ake kira CB1.
Maganin, a cewar Dr. Scott Hadland yana toshe tasirin euphoric na cannabis. Zai ko da yaushe kare kashe mafi kyau a cikin mutanen da da gaske son daina amfani. Yana da mahimmanci cewa wannan magani ya zama samuwa.
Source: nbcnews.com (En)
